Topical Cidofovir for Recalcitrant Verrucae in Individuals with Severe Combined Immunodeficiency After Hematopoietic Stem Cell Transplantation

We describe two brothers with X‐linked SCID who had severe, persistent verrucae that did not respond to traditional topical therapies, including liquid nitrogen, imiquimod, salicylic acid, sinecatechins, 40% urea, and 5‐fluorourcil. Both brothers had full response to topical 3% cidofovir, which should be considered in recalcitrant warts in individuals with SCID after HSCT.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fpde.12992

Source: Pediatric Dermatology - October 3, 2016 Category: Dermatology Authors: Sarah E. Henrickson, James R. Treat Tags: Brief Report Source Type: research